Supplemental material
Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Coronaviruses
Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Ji-Min Seoa Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0003-2687-7495View further author information
https://orcid.org/0000-0003-2687-7495View further author information, Bobin Kanga Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0002-0551-5391View further author information
https://orcid.org/0000-0002-0551-5391View further author information, Rina Songa Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0003-3036-959XView further author information
https://orcid.org/0000-0003-3036-959XView further author information, Hanmi Noha Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0001-7515-8740View further author information
https://orcid.org/0000-0001-7515-8740View further author information, Cheolmin Kima Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0001-7810-5601View further author information
https://orcid.org/0000-0001-7810-5601View further author information, Jong-In Kima Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0001-7376-1036View further author information
https://orcid.org/0000-0001-7376-1036View further author information, Minsoo Kima Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0003-4394-6528View further author information
https://orcid.org/0000-0003-4394-6528View further author information, Dong-Kyun Ryua Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0003-4237-4740View further author information
https://orcid.org/0000-0003-4237-4740View further author information, Min-Ho Leeb New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Koreahttps://orcid.org/0000-0003-0197-3456View further author information
https://orcid.org/0000-0003-0197-3456View further author information, Jeong-Sun Yangc Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Koreahttps://orcid.org/0000-0001-5005-9738View further author information
https://orcid.org/0000-0001-5005-9738View further author information, Kyung-Chang Kimc Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Koreahttps://orcid.org/0000-0002-1075-0804View further author information
https://orcid.org/0000-0002-1075-0804View further author information, Joo-Yeon Leec Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Koreahttps://orcid.org/0000-0002-0993-9626View further author information
https://orcid.org/0000-0002-0993-9626View further author information, Hansaem Leec Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Koreahttps://orcid.org/0000-0002-9430-8123View further author information
https://orcid.org/0000-0002-9430-8123View further author information, Hye-Min Wooc Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Koreahttps://orcid.org/0000-0001-8020-3489View further author information
https://orcid.org/0000-0001-8020-3489View further author information, Jun-Won Kimc Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Koreahttps://orcid.org/0000-0001-9393-4248View further author information
https://orcid.org/0000-0001-9393-4248View further author information, Jung-Ah Choid Science Unit, International Vaccine Institute, Seoul, Republic of Koreahttps://orcid.org/0000-0003-2381-7374View further author information
https://orcid.org/0000-0003-2381-7374View further author information, Manki Songd Science Unit, International Vaccine Institute, Seoul, Republic of Koreahttps://orcid.org/0000-0002-8279-9041View further author information
https://orcid.org/0000-0002-8279-9041View further author information, Monika Tomaszewska-Kiecanae Biokinetica S.A. Phase 1 Unit, Jozefow, Polandhttps://orcid.org/0000-0001-8501-5479View further author information
https://orcid.org/0000-0001-8501-5479View further author information, Anna Wołowike Biokinetica S.A. Phase 1 Unit, Jozefow, Polandhttps://orcid.org/0000-0003-2913-948XView further author information
https://orcid.org/0000-0003-2913-948XView further author information, Agnieszka Kuleszae Biokinetica S.A. Phase 1 Unit, Jozefow, Polandhttps://orcid.org/0000-0002-0006-9433View further author information
https://orcid.org/0000-0002-0006-9433View further author information, Sunghyun Kima Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0003-3898-0393View further author information
https://orcid.org/0000-0003-3898-0393View further author information, Keumyoung Ahna Celltrion Inc, Incheon, Republic of Koreahttps://orcid.org/0000-0002-9370-5338View further author information
https://orcid.org/0000-0002-9370-5338View further author information, & Soo-Young Leea Celltrion Inc, Incheon, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-3306-9333View further author information
https://orcid.org/0000-0002-3306-9333View further author information show all